Wealth Management Associates, Inc. Abb Vie Inc. Transaction History

Wealth Management Associates, Inc.

$233 Billion
Q1 2025

A detailed history of Wealth Management Associates, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Management Associates, Inc. holds 7,019 shares of ABBV stock, worth $1.31 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

7,019

Previous 7,013 0.09%

Holding current value

$1.31 Million

Previous $1.25 Billion 18.0%

% of portfolio

0.63%

Previous 0.53%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 28, 2025	BUY	$169.2 - $216.66 $1,015 - $1,299	6 Added 0.09%	7,019 $1.47 Billion
Q4 2024 May 28, 2025	BUY	$164.99 - $203.87 $15,014 - $18,552	91 Added 1.31%	7,013 $1.25 Billion
Q3 2024 May 28, 2025	BUY	$163.84 - $199.33 $819 - $996	5 Added 0.07%	6,922 $1.37 Billion
Q1 2024 May 28, 2025	SELL	$159.82 - $182.1 $56,416 - $64,281	-353 Reduced 4.86%	6,917 $1.19 Billion
Q4 2023 May 28, 2025	SELL	$137.6 - $154.97 $50,912 - $57,338	-370 Reduced 4.84%	7,270 $1.13 Billion
Q3 2023 May 28, 2025	SELL	$133.59 - $154.65 $56,241 - $65,107	-421 Reduced 5.22%	7,640 $1.14 Billion
Q2 2023 May 28, 2025	SELL	$132.51 - $164.9 $3,975 - $4,947	-30 Reduced 0.37%	8,061 $1.09 Billion
Q1 2023 May 28, 2025	SELL	$144.61 - $166.54 $9,544 - $10,991	-66 Reduced 0.81%	8,091 $1.29 Billion
Q4 2022 May 28, 2025	SELL	$138.31 - $165.87 $159,056 - $190,750	-1,150 Reduced 12.36%	8,157 $1.32 Billion
Q3 2022 May 28, 2025	BUY	$134.21 - $153.93 $1,207 - $1,385	9 Added 0.1%	9,307 $1.25 Billion
Q2 2022 May 28, 2025	BUY	$137.62 - $174.96 $394,418 - $501,435	2,866 Added 44.56%	9,298 $1.42 Billion
Q1 2022 May 28, 2025	BUY	$131.98 - $163.75 $55,959 - $69,430	424 Added 7.06%	6,432 $1.04 Billion
Q4 2021 May 28, 2025	BUY	$107.43 - $135.93 $107,752 - $136,337	1,003 Added 20.04%	6,008 $814 Million
Q3 2021 May 28, 2025	BUY	$106.4 - $120.78 $142,576 - $161,845	1,340 Added 36.56%	5,005 $540 Million
Q2 2021 May 28, 2025	BUY	$105.21 - $117.21 $3,682 - $4,102	35 Added 0.96%	3,665 $413 Million
Q1 2021 May 28, 2025	BUY	$102.3 - $112.62 $29,973 - $32,997	293 Added 8.78%	3,630 $393 Million
Q4 2020 May 28, 2025	SELL	$80.49 - $108.67 $1,770 - $2,390	-22 Reduced 0.65%	3,337 $358 Million
Q3 2020 May 28, 2025	BUY	$85.91 - $100.83 $8,075 - $9,478	94 Added 2.88%	3,359 $294 Million
Q2 2020 May 28, 2025	BUY	$73.37 - $98.18 $35,437 - $47,420	483 Added 17.36%	3,265 $321 Million
Q1 2020 May 28, 2025	SELL	$64.5 - $97.79 $6,256 - $9,485	-97 Reduced 3.37%	2,782 $212 Million
Q4 2019 May 28, 2025	BUY	$72.13 - $90.25 $207,662 - $259,829	2,879 New	2,879 $255 Million
Q1 2019 May 28, 2025	SELL	$77.14 - $90.79 $190,690 - $224,432	-2,472 Closed	0 $0
Q4 2018 May 28, 2025	BUY	$77.85 - $96.01 $192,445 - $237,336	2,472 New	2,472 $228 Million

Others Institutions Holding ABBV

# of Institutions

4,264

Shares Held

1.27B

Call Options Held

18.2M

Put Options Held

15.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $329B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Management Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wealth Management Associates, Inc. with notifications on news.

Account

Wealth Management Associates, Inc. Abb Vie Inc. Transaction History